“These data demonstrate that CBDV, when administered chronically and starting at juvenile age, holds a solid therapeutic potential for FXS.”
Topic: Health/Safety
“CBD may serve as a useful adjunct for some children with CP, especially those with worse disease severity,” the study’s authors concluded.
“Results showed both statistically significant and clinically meaningful improvements in people with chronic health conditions,” investigators concluded.
The study’s authors concluded, “The present study demonstrated that cannabis is used as an ergogenic recovery aid by individuals that exercise regularly.”
Following subjects’ use of cannabis for three weeks, researchers “identified a trend toward [a] reduction in PTSD symptoms.”
Only 38 percent of respondents acknowledged “receiving any education on cannabis in their nursing program.”
Researchers concluded, “Our study expands the scientific data demonstrating that clinical use of cannabis extracts is a safe intervention with promising and valuable effects.”
Ninety-two percent of unregulated flower products tested in the study came back positive for the residual presence of pesticides.